Identifying SVO therapeutic interventions, such as resistance training, protein-optimized nutrition, and insulin-sensitizing therapies—strategies shown to reverse both sarcopenia and hepatic steatosis [23]. The gene discussed is INS; the disease is fatty liver disease.